Compare ARK Genomic Revolution ETF (ARKG) vs Expedia Group Inc (EXPE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Expedia Group Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Expedia Group Inc trades at $321.83 (market cap $38.53B). The key difference: Expedia Group Inc pays a 0.6% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | EXPE | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $44.55 | $321.07 |
52-Week Low | $24.02 | $188.51 |
Market Cap | — | $38.53B |
Enterprise Value | — | $37.09B |
Dividend Yield | — | 0.6% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Expedia Group Inc
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →
